Content
Welcome to BIO! Below you'll find more information on the organization and resources to get involved.
A world where scientific innovations made possible through biotechnology conquer disease, sustain our environment, and advance nutrition and healthfulness.
To advance biotechnology innovation by promoting sound public policy and fostering collaboration, both locally and globally.
BIO is the world's largest trade association with 1,000 member companies, representing all of biotechnology.
Michelle McMurry-Heath assumed the leadership of the Biotechnology Innovation Organization (BIO) as President and CEO on June 1, 2020. A medical doctor and molecular immunologist by training, Dr. McMurry-Heath becomes just the third chief executive to steward the world’s largest biotechnology advocacy group since BIO’s founding in 1993.
Get free access to 25 BIO Digital Sessions, including several with Merck scientists. Topics include a fireside chat with Dr. Fauci; Equity, Diversity, and Inclusion; COVID-19 Vaccine & Therapy Development; Patient Voice & Perspective.
Tracking all the industry's efforts on diagnostics, therapeutics and vaccines – including Merck.
Interactive pipeline tracker for all therapies and vaccines – there are nearly 550 programs!
A directory tracking the patient support programs available during coronavirus.
Designed to provide key information to keep your employees safe and business operating.
Designed to provide key scientific resources to advance development and manufacturing capacity.
Created to connect companies with capacity and resources with those that need them.
Provides an overview of how Agriculture & Environmental Biotech is responding to COVID-19.
Sign-up to receive the Good Day BIO newsletter, the only daily newsletter at the intersection of biotech, politics and policy.
BIO has launched a new campaign to tell the story of biotechnology through the eyes of those making a societal impact through science and those whose lives were changed forever because of scientific breakthroughs. Help us put a face to biotech and introduce the hidden heroes in our labs by sharing your story.
As Moderna breaks the record for speed on starting its final stage of human testing for its covid vaccine, new BIO CEO Dr. Michelle McMurry-Heath tackles the the thorny issue of how to best structure the historic Phase 3 clinical trial with the Boston biotech’s Chief Medical Officer.
Subscribe on: Apple Podcasts, Google Podcasts, Spotify, or your player of choice.
